○Yuki Obata¹, Hiroyuki Togawa¹, Yumi Nonaka¹, Tomoko Araki¹, Hiroshi Sakamaki¹ (1. Chemicals Evaluation and Research Institute, Japan)

○Takenori Yamamoto¹, Birei Furuta¹, Takuma Yamashita¹, Eriko Uchida¹, Takao Inoue² (1. Div. Mol, Target and Gene Therapy, Gene Therapy lab, NIHS, 2. Div. Mol, Target and Gene Therapy, NIHS)

○Kazuma Fujisawa¹, Koichi Machida¹, Akira Kotani¹, Kazuhiro Yamamoto¹, Hideki Hakamata¹ (1. Tokyo University of Pharmacy and Life Sciences)

Shinichi Fujisaki¹, ○Takuya Yoshioka¹, Satoru Watanabe¹, Yuichiro Fujita¹, Tomohiro Kawase¹, Keiko Matsumoto¹ (1. Shimadzu Corporation)

○Kazuma Ando¹, Manami Suzuki¹, Rie Hiratsuka¹, Fukue Takayanagi¹, Tomoko Fukuuchi¹, Daisuke Saigusa¹, Makoto Yasuda¹, Ken-ichi Mawatari¹, Naoto Oku¹, Kiyoko Kaneko², Noriko Yamaoka¹ (1. Faculty of Pharma-Sciences, Teikyo University , 2. Faculty of Pharmaceutical Sciences Teikyo Heisei University )

○Kaito Aoki¹, Takaaki Kannno¹, Rie Hiratsuka¹, Fukue Takayanagi¹, Tomoko Fukuuchi¹, Daisuke Saigusa¹, Makoto Yasuda¹, Ken-ichi Mawatari¹, Naoto Oku¹, Kiyoko Kaneko², Noriko Yamaoka¹ (1. Faculty of Pharma-Sciences, Teikyo University, 2. Faculty of Pharmaceutical Sciences, Teikyo Heisei University)

○Shunichi Ishikawa¹, Hana Kozaki¹, Masahiko Tachi², Susumu Y. Imanishi¹ (1. Faculty of Pharmacy, Meijo University, 2. Aichi Prefectural Institute of Public Health)

○Kouta Ninomiya¹, Satoko Shimbara-Matsubayashi^1,2, Maho Kamemoto¹, Asami Ogura¹, Koji Karasawa¹, Kenji Momo¹, Tadanori Sasaki³, Masaru Kato¹ (1. Sch. Pharm., Showa Univ., 2. Cent. Mol. Anal., Showa Univ. , 3. Dept. Pharm., Showa Univ. Hsp.)

○Mihoyo Fujitake¹, Shinya Harusawa¹ (1. Osaka Medical and Pharmaceutical University)

○Keita Saito¹, Yusuke Egawa¹, Hiroyuki Kataoka¹ (1. School of Pharmacy, Shujitsu University)

○Daiki Takeuchi¹, Jo Sakata¹, Yoshihiro Kato¹, Hajime Mizuno¹, Shinobu Kudoh², Iwao Sakane³, Eiji Sugiyama¹, Kenichiro Todoroki¹ (1. Shc. Pharm. Sci., University of Shizuoka, 2. Yokogawa Electric Corporation, 3. ITO EN Ltd)

○Yukino Yamaguchi¹, Kimika Nisijima¹, Hajime Mizuno¹, Sachise Karakawa², Masashi Harada², Eiji Sugiyama¹, Akira Nakayama², Kenichiro Todoroki¹ (1. Sch.Pharm.Sci.,University of Shizuoka, 2. Ajinomoto Co. Inc)

○Kohei Sugimoto¹, Kenji Kojima¹, Kousuke Hirata¹, Yuri Ishigaki¹, Kazuki Saito¹ (1. Faculty of Pharmaceutical Sciences, Himeji Dokkyo University)

○Maiko Tahara¹, Tsuyoshi Kawakami¹, Yoshiaki Ikarashi¹ (1. National Institute of Health Sciences)

○Chisato Tode¹, Chikako Moriyama¹, Atsuko Takeuchi¹ (1. KobePharmaceuticalUniversity)

○Yuichi Kida¹, Haruaki Ishiyama¹ (1. The School of Pharmaceutical sciences, Ohu University)

○Hirofumi Tsujino^1,2, Keisuke Tachibana¹ (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. Museum, Osaka Univ.)

○Aki Tanaka¹, Atsuko Konishi¹, Shigehiko Takegami¹ (1. Kyoto Pharm. Univ.)

○Izumi Morita¹, Hiroyuki Oyama¹, Yuki Kiguchi¹, Rie Tanaka², Jun Ogata², Ruri Kikura-Hanajiri², Norihiro Kobayashi¹ (1. Kobe Pharm. Univ., 2. NIHS)

○Yuki Kiguchi¹, Hiroyuki Oyama¹, Izumi Morita¹, Ai Osawa¹, Norihiro Kabayashi¹ (1. Kobe Pharm. Univ.)

○Hiroyuki Oyama¹, Yuka Yamakoshi¹, Asahi Ikeda¹, Izumi Morita¹, Yuki Kiguchi¹, Norihiro Kobayashi¹ (1. Kobe Pharm Univ)